The Nutshell
Why is US citation share dropping?
Kerry Grens | Jul 20, 2007
The National Science Foundation released two reports to the public this week that examine a puzzling trend: Why, during times of increasing investment in science, is the share of US publications dropping? As I linkurl:reported; in November of last year, US publication numbers plateaued from 1992 to 2002, and the global percentage of publications coming out of the US dropped from 38% in 1973 to 30% in 2003. Meanwhile, the report shows US academic R&D
Breathing freely over TB patient
Alison McCook | Jul 3, 2007
Officials at the Centers for Disease Control and Prevention are likely taking a collective sigh of relief. This just in from The Scientist intern Kelly Chi: Today (July 3) representatives from the National Jewish Medical Research Center and the CDC revealed that Andrew Speaker, a patient who sparked international concern after traveling with a highly-resistant form of TB, has multi-drug resistant TB (MDR-TB), not extensively drug-resistant TB (XDR-TB). This means that he can be treated with a
More labs go green all over
Bob Grant | Jul 3, 2007
It appears that the link between science and building green is strengthening with each passing day. Last week, Arizona State University announced its choice of HDR Architects and Steven Ehrlich Architects to design its new Interdisciplinary Science and Technology Building (ISTB) IV scheduled for completion on its Tempe campus by 2010. The university plans to seek a minimum of LEED Silver status for the 250,000-square-foot building, which will house offices and laboratories for ASU's School of Ea
For one patient, stem cells show promise
Ivan Oransky | Jul 2, 2007
In this week's Lancet, several Norwegian cardiologists linkurl:urge caution; before testing stem cell therapies in patients following heart attacks. Three of the clinical trials so far haven't shown any positive effects, and the one that did was questionable, they write. At least one patient in Michigan didn't like being subjected to one such experiment in 2003; he's linkurl:suing;
Bye bye, Donald Kennedy
Alison McCook | Jun 22, 2007
Yesterday (June 21), Science editor-in-chief Donald Kennedy announced he was retiring from the journal, after seven years at the helm. AAAS president David Baltimore is leading a search committee for a new candidate. Kennedy has steered Science through some tricky waters, to say the least. The journal published, then retracted, one of Woo-Suk Hwang's linkurl:now-infamous; papers on human embryonic stem cell research. In 2002, the journal lin
Hwang back at work
Alison McCook | Jun 22, 2007
South Korean researcher Woo-suk Hwang has apparently picked up the pieces of his life since he admitted to fabricating key findings in human embryonic stem cell research. According to the Associated Press, he has linkurl:opened a private lab; outside of Seoul, and taken 30 researchers with him. They are now extracting stem cells from cloned animal embryos, such as pigs and cows. "If we had been working
Good news for pygmy rabbits
Ivan Oransky | Jun 19, 2007
Finally, after years of dwindling populations and a deadly outbreak in February and March, there may be some good news for Columbia Basin pygmy rabbits. I traveled out to Washington and Oregon to linkurl:report on efforts to save the species; for our June issue. The Associated Press linkurl:reported last week; that doctoral student Len Zeoli had found a ''female digging a burrow and lining it wit
Hwang ghost appears at stem cell conference
Stephen Pincock | Jun 19, 2007
The spectre of linkurl:Hwang Woo-Suk; has raised its head a couple of times at the annual meeting of the linkurl:International Society for Stem Cell Research; in Cairns, Australia. On Monday, incoming ISSCR president George Daley, from Children's Hospital Boston, was describing the potential value of deriving stem cells parthenogenetically when he mentioned the name which pricks up everyone's ears. Daley said that ana
Dutch postdocs treated like royalty
Edyta Zielinska | Jun 15, 2007
Thanks in part to our linkurl:Best Places to Work as a Postdoc; surveys, 150 postdocs throughout The Netherlands will be spending three days in a four-star hotel in Bergen. That's according to Peter Peters, dean of postdoc affairs at linkurl:The Netherlands Cancer Institute;, which just won a 100,000-euro grant from linkurl:The Association of Dutch Universities; to expand its training progr
Steve Nissen goes 0 for 2
Ivan Oransky | Jun 14, 2007
An FDA advisory panel has ''unanimously rejected Acomplia, a weight-loss drug from Sanofi-Aventis, on concerns the drug increases the number of psychiatric events like depression and suicidal thinking among users,'' Dow Jones Newswires linkurl:reported; yesterday. That means it's at least the second time in under a year that Steven Nissen has been wrong about the promise of new drugs. Nissen, of course, is the well-known Cleveland Clinic ca